Quantcast

Latest Alzheimer's disease Stories

2014-07-16 04:21:29

ATTN: Please refer to www.alz.org/aaic/press.asp or call (312) 335-4078 for individual stories included here that were presented before Wednesday, July 16, and have come off embargo. COPENHAGEN, Denmark, July 16, 2014 /PRNewswire-USNewswire/ -- New studies reported at the Alzheimer's Association International Conference 2014 (AAIC® 2014) in Copenhagen cover the spectrum of Alzheimer's disease and dementia research. Data includes advances in early detection and diagnosis, identifying...

2014-07-16 04:21:24

- New Brain Protein Connected for First Time to Cognitive Decline and Alzheimer's Disease. COPENHAGEN, Denmark, July 16, 2014 /PRNewswire-USNewswire/ -- Results from four research studies reported as "developing topics" at the Alzheimer's Association International Conference(®) 2014 (AAIC(®) 2014) in Copenhagen include significant advances in evidence regarding treatment and early detection of Alzheimer's disease and dementia, as well as new ideas in the basic brain science of dementia that...

2014-07-15 12:28:31

Two drugs to be studied in North America and Europe in volunteers at high risk for disease COPENHAGEN, Denmark, July 15, 2014 /PRNewswire/ -- Researchers from the Banner Alzheimer's Institute (BAI) today announced a partnership with Novartis in a pioneering medical trial to determine whether two investigational anti-amyloid drugs--an active immunotherapy and an oral medication--can prevent or delay the emergence of symptoms of Alzheimer's in people at particularly high risk for...

2014-07-15 12:28:19

A genetic variant conveys significant protection MONTREAL, July 15 2014 /CNW Telbec/ - Judes Poirier, PhD, C.Q., from the Douglas Mental Health Institute and McGill University in Montréal (Canada) and his team have discovered that a relatively frequent genetic variant actually conveys significant protection against the common form of Alzheimer's disease and can delay the onset of the disease by as much as 4 years. This discovery opens new avenues for treatment against this...

2014-07-15 04:22:22

ABERDEEN, Scotland and SINGAPORE, July 15, 2014 /PRNewswire/ -- TauRx Therapeutics Ltd [http://www.taurx.com ] today announced it has achieved its target enrolment of 833 subjects into one of its two ongoing multi-centre Phase III clinical trials of LMTX(TM) [http://taurx.com/lmtx-for-ad ], a tau aggregation inhibitor, for the treatment of Alzheimer's Disease [AD]. This placebo-controlled clinical trial (Protocol TRx-237-015 [http://taurx.com/015-clinical-study.html ]) has...

2014-07-15 04:22:13

Study Results Presented at the Alzheimer's Association International Conference 2014 INDIANAPOLIS, July 15, 2014 /PRNewswire/ -- Today, Eli Lilly and Company (NYSE:LLY) announced results from an analyses of five datasets evaluating the relationship between cognitive and functional impairment in patients with mild Alzheimer's disease in the natural course of the disease. Analysis findings demonstrate that cognitive deficits predict subsequent functional deficits and suggest that...

2014-07-15 04:22:07

New data on fewer new cases in developed nations suggests possibility of prevention and risk reduction COPENHAGEN, Denmark, July 15, 2014 /PRNewswire-USNewswire/ -- While the global epidemic of Alzheimer's disease continues to grow, new data on lower incidence in the "youngest old" from developed countries in Europe and the United States suggest the possibility of reducing risk and/or preventing the disease, according to the results of several research studies announced at the Alzheimer's...

2014-07-15 04:22:04

COPENHAGEN, Denmark, July 15, 2014 /PRNewswire-USNewswire/ -- The Alzheimer's Association International Conference(®) (AAIC 2014(®)) will host health leaders from G7 governments to continue discussing the Global Action Against Dementia Legacy Events stemming from the first-ever G8 (now G7) Dementia Summit organized by U.K. Prime Minister Cameron in December 2013. As the world's premier forum for Alzheimer's disease and related dementias, AAIC 2014 will serve as the platform for a global...

2014-07-14 12:59:11

Alzheimer's Association New data on possible protective behaviors and dementia risk factors emerges at Alzheimer's Association International Conference 2014 Participation in activities that promote mental activity, and moderate physical activity in middle age, may help protect against the development of Alzheimer's disease and dementia in later life, according to new research reported today at the Alzheimer's Association International Conference® 2014 (AAIC® 2014) in Copenhagen....

2014-07-14 12:20:58

Cedars-Sinai Medical Center Preliminary results show the device, created at Cedars-Sinai and developed by NeuroVision Imaging, may provide highly predictive early detection of changes associated with Alzheimer's disease A noninvasive optical imaging device developed at Cedars-Sinai can provide early detection of changes that later occur in the brain and are a classic sign of Alzheimer's disease, according to preliminary results from investigators conducting a clinical trial in...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related